Results 171 to 180 of about 184,721 (306)

52 Biotin Interference With the Biotin-Streptavidin-Based VITROS Hepatitis B e Antigen (HBeAg) and Hepatitis B e Antibodies (Anti-HBe) Immunoassays [PDF]

, 2018
Jose Jara Aguirre, Joseph D. Yao, Theodore Stier, Elitza S. Theel   +3 more
openalex   +1 more source

Pre‐diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case–control analysis of 12 prospective cohorts

International Journal of Cancer, EarlyView.
What's New? Disruption of the gut–liver axis has been suggested to play an important role in liver carcinogenesis. However, limited prospective research has explored associations between potentially harmful gut‐derived bacterial products and liver cancer risk.
Cody Z. Watling, Peter T. Campbell, Barry I. Graubard, Yanyu Wang, Andrew T. Gewirtz, Xuehong Zhang, Matthew J. Barnett, Julie E. Buring, Yu Chen, A. Heather Eliassen, J. Michael Gaziano, Jonathan N. Hofmann, Wen‐Yi Huang, Jae H. Kang, Jill Koshiol, Erikka Loftfield, I‐Min Lee, Steven C. Moore, Lorelei A. Mucci, Marian L. Neuhouser, Christina C. Newton, Mark P. Purdue, Howard D. Sesso, Martha Shrubsole, Rashmi Sinha, Lesley Tinker, Matthew Triplette, Caroline Y. Um, Kala Visvanathan, Eleanor L. Watts, Jean Wactawski‐Wende, Walter Willett, Fen Wu, Wei Zheng, Dinesh Barupal, Jessica L. Petrick, Katherine A. McGlynn   +36 more
wiley   +1 more source

Performance of Elecsys Anti-HEV IgG and IgM Assays for the Detection of Acute, Recent or Past Hepatitis E Virus Infection. [PDF]

Liver Int
Schemmerer M, Pflüger LS, Schneider T, Lu J, Kienle K, Meyer-Schlinkmann KM, Mühlbacher A, Polz J, Schennach H, Xie Q, Voitenleitner C, Wenzel J, Lütgehetmann M.   +12 more
europepmc   +1 more source

Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases

, 2023
Didem Gülcü Taşkın
openalex   +1 more source

Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis

International Journal of Cancer, EarlyView.
What's New? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke, Karl Mayrhofer, Johanna Krauter, Johannes Franke, Dominic Vais, Maximillian Pallauf, David Kiesl, Ferdinand Luger, Jacob Pfuner, Angelika Terbuch, Thomas Bauernhofer, Jasmin Spielgelberg, Andreas Banner, Stefan Aufderklamm, Clemens Wiesinger, Susanne Schnabel, Simon Peter Gampenrieder, Josef Mühlmann, Sonia Vallet, Sabine Weibrecht, Franz Stoiber, Haleh Andalibi, Harun Fajkovic, Hossein Taghizadeh, Jan Miechowiecki, Roman Taedcke, Daniel Heintel, Shahrokh F. Shariat, Martin Pichler, Wolfgang Hilbe, Renate Pichler   +30 more
wiley   +1 more source

Navigating the Latest Hepatitis B Virus Reactivation Guidelines. [PDF]

Diseases
Elharabi Z, Saba J, Akin H.
europepmc   +1 more source

Five‐year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non‐small‐cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE‐042 China study

International Journal of Cancer, EarlyView.
What's New? Global research has found that for people newly diagnosed with advanced non‐small cell lung cancer (NSCLC), the anti‐PD‐1 monoclonal antibody pembrolizumab on its own often leads to better results than traditional chemotherapy. The present report details long‐term findings of pembrolizumab therapy specifically among Chinese patients.
Yi‐Long Wu, Li Zhang, Yun Fan, JianYing Zhou, Li Zhang, Qing Zhou, Wei Li, ChengPing Hu, GongYan Chen, Xin Zhang, CaiCun Zhou, Carmen González Arenas, Zhenghong Chen, Wen Cheng Yu, Tony S. K. Mok   +14 more
wiley   +1 more source

Hepatitis Vaccines: Recent Advances and Challenges. [PDF]

Vaccines (Basel)
Lu M, Liu Y, Li L, Liu X, Wu B, Wu Y.
europepmc   +1 more source

Utilization of Donors with Hepatitis B Core Antibodies in Liver Transplantation

, 2015
Michał Skalski, Waldemar Patkowski, Michał Grąt, Krzysztof Zieniewicz, Tadeusz Wróblewski, Wacław Hołówko, Marek Krawczyk   +6 more
openalex   +1 more source

P050: Novel broadly‐reactive neutralizing antibodies against hepatitis B virus surface antigen [PDF]

, 2015

openalex   +1 more source